Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: Association with asthma severity, neutrophilic inflammation, and wound repair

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 6, 2003, Pages 1345-1352

  Wenzel, Sally E ^a   Balzar, Silvana ^a   Cundall, Meghan ^a   Chu, Hong Wei ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Asthma; Matrix metattoproteinase; Neutrophils; Pathology

Indexed keywords

COLLAGEN TYPE 1; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; ASTHMA; BASEMENT MEMBRANE; BRONCHUS BIOPSY; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ANALYSIS; EOSINOPHIL; EPITHELIUM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INFLAMMATORY CELL; LUNG FUNCTION; LUNG LAVAGE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; STAINING; SUBMUCOSA; THICKNESS; WOUND HEALING;

EID: 0037504020     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1464     Document Type: Article

References (23)

1. Raza SL, Cornelius LA. Matrix metalloproteinases and their native or pharmacologic inhibitors. Adv Dermatol 2000;16:185-209.
2. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997;276:75-81.
3. Delclaux C, Delacourt C, d'Ortho M-P, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996;14:288-95.
4. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
5. Lemjabbar H, Gosset P, Lamblin C, et al. Contribution of 92 kDa gelatinase/Type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999;159:1298-307.
6. Vignola AM, Riccobono L, Mirabella A, et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998;158:1945-50.
7. Tanaka H, Miyazaki N, Oashi K, Tanaka S, Ohmichi M, Abe S. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in actue asthma. J Allergy Clin Immunol 2000;105:900-5.
8. Dahlen B, Shute J, Howarth P. Immunohistochemical localization of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 1999;54:590-6.
9. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-8.
10. Chu HW, Wang JM, Boutet M, Boulet L-P, Laviolette M. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in a murine model of pulmonary eosinophila and high IgE level. Clin Exp Immunol 1995;100:319-24.
11. Chu HW, Halliday JL, Martin RJ, Leung DYM, Szefler SJ, Wenzel SE. Collagen deposition in large airways does not appear to differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 1998;158:1936-44.
12. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair. Int J Mol Med 2000;6:391-407.
13. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995;9:974-80.
14. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicomhe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000;105:193-204.
15. Chu HW, Trudeau JB, Balzar S, Wenzel S. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 2000;106:1115-1123.
16. Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999;104:356-63.
17. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519-28.
18. Kumagai K, Ohno I, Okada S, et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 1999;162:4212-9.
19. Corry DB, Rishi K, Kanellis J, et al. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol 2002;3:347-53.
20. Cataldo DD, Tournoy KG, Vermaelen K, et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol 2002;161:491-8.
21. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-43.
22. Maestrelli P, Saetta M, Di Stefano A, et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995;152:1926-31.
23. Grootendorst DC, Sont JK, Willems LN, et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy 1997;27:769-79.